Search results for "Treatment options"

showing 10 items of 88 documents

Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity.

2013

Background Guidelines for chronic obstructive pulmonary disease (COPD) recommend that treatment choices be based partly on symptoms. Methods A post-hoc analysis of pooled data from clinical studies compared the efficacy and safety of once-daily inhaled bronchodilators indacaterol (150 and 300 μg) and open-label tiotropium (18 μg) according to baseline dyspnoea severity on the modified Medical Research Council (mMRC) scale in patients with COPD (mMRC scores <2 = ‘less dyspnoea’; scores ≥2 = ‘more dyspnoea’). Outcomes were assessed after 26 weeks. Results The analysis included 3177 patients. In patients with less dyspnoea: indacaterol (both doses) improved 24-h post-dose (‘trough’) forced exp…

Pulmonary and Respiratory MedicineCopd patientsScopolamine DerivativesPulmonary diseaseQuinolonesPlaceboPulmonary Disease Chronic ObstructiveForced Expiratory VolumeMedicineHumansPharmacology (medical)In patientPooled dataTiotropium BromideRandomized Controlled Trials as TopicCOPDDose-Response Relationship Drugbusiness.industryBiochemistry (medical)Patient AcuityTreatment optionsmedicine.diseaserespiratory tract diseasesBronchodilator AgentsDyspneaAnesthesiaDelayed-Action PreparationsIndansIndacaterolbusinessmedicine.drugPulmonary pharmacologytherapeutics
researchProduct

Guías EAU sobre incontinencia urinaria

2011

Contexto: Las primeras directrices sobre incontinencia de la European Association of Urology (EAU) se publicaron en 2001. Dichas directrices se han actualizado con regularidad en los últimos años. Objetivo: El objetivo de este artículo es ofrecer un resumen de la actualización de las directrices sobre incontinencia urinaria (IU) de la EAU realizada en 2009. Recogida de evidencias: El comité de trabajo de la EAU formó parte de la IV Consulta Internacional sobre Incontinencia (ICI) y, con permiso de la ICI, llevó a cabo la extracción de la información de relevancia. La metodología de la IV ICI consistió en una amplia revisión de la literatura por parte de expertos internacionales y en la crea…

RevisiónMalemedicine.medical_specialtydiagnosisassessmentUrologyUrinary systemUrinary incontinencereviewMEDLINEPsychological interventionConsensus formationUrinary incontinenceContext (language use)ReviewUrinary incontinence; EAU guidelines; Review; Assessment; Diagnosis; TreatmentAssessmentPharmacotherapyeau guidelines; treatment; diagnosis; urinary incontinence; assessment; reviewUrinary incontinence EAU guidelines Review Assessment Diagnosis TreatmentDiagnosisTratamientoHumansMedicineEAU guidelinesWeb siteGynecologyEvidence-Based MedicineEvaluacióntreatmentbusiness.industryDiagnósticoGuías EAUTreatment optionseau guidelinesGeneral MedicineEvidence-based medicineIncontinencia urinariaTreatmentUrinary IncontinencePractice Guidelines as TopicPhysical therapyFemalemedicine.symptombusinessAlgorithmsActas Urológicas Españolas (English Edition)
researchProduct

Implant-supported overdenture with horizontal insertion for treating the edentulous atrophic maxilla: A case series

2020

Abstract Statement of problem Rehabilitation of edentulous patients with severe maxillary atrophy is a clinical challenge. Although several treatment options are available, the implant-supported overdenture has been widely advocated. However vertical insertion implant-supported overdentures have drawbacks, including wear, aging, and the continuous maintenance of retention systems. Whether an implant-supported overdenture with a horizontal insertion pathway can overcome these problems is unclear. Purpose The purpose of this observational study was to determine the clinical and biological behavior of a new type of implant-supported overdenture with a horizontal insertion pathway over a mean c…

Visual analogue scalemedicine.medical_treatmentDentistryEsthetics Dental03 medical and health sciences0302 clinical medicinePatient satisfactionMaxillaAtrophic maxillamedicineHumansJaw EdentulousDental ImplantsRehabilitationbusiness.industryTreatment options030206 dentistryDenture OverlayTreatment OutcomePatient SatisfactionDental Prosthesis Implant-SupportedImplantMouth EdentulousAtrophyOral SurgerybusinessImplant supportedFollow-Up StudiesThe Journal of Prosthetic Dentistry
researchProduct

Survey based assessment of diagnosis through periapical radiograph and CBCT and treatment of root resorption with Brazilian and American dentists and…

2020

Background This study assesses and compares the knowledge level of endodontists (ENDs) and general dental practitioners (GPs) from Brazil and United States of America (USA) in the diagnosis and treatment of internal and external inflammatory root resorptions through periapical radiographic (PA) and cone beam computed tomography (CBCT) examinations. Material and Methods A cross-sectional online questionnaire-based survey was presented to the volunteers containing questions regarding personal and professional profile, as well as three clinical cases of internal and external inflammatory root resorption. A series of multiple-choice questions about the diagnosis and treatment options were surve…

business.industryResearchPeriapical radiographyRadiographyDentistryTreatment optionsRoot resorptionmedicine.diseaseCorrect responseOperative Dentistry and EndodonticsStatistical significanceMedicinebusinessGeneral DentistryUNESCO:CIENCIAS MÉDICASEndodontistJournal of Clinical and Experimental Dentistry
researchProduct

Total Synthesis of a Partial Structure from Arabinogalactan and Its Application for Allergy Prevention

2020

Abstract Arabinogalactan, a microheterogeneous polysaccharide occurring in plants, is known for its allergy‐protective activity, which could potentially be used for preventive allergy treatment. New treatment options are highly desirable, especially in a preventive manner, due to the constant rise of atopic diseases worldwide. The structural origin of the allergy‐protective activity of arabinogalactan is, however, still unclear and isolation of the polysaccharide is not feasible for pharmaceutical applications due to a variation of the activity of the natural product and contaminations with endotoxins. Therefore, a pentasaccharide partial structure was selected for total synthesis and subse…

chemistry.chemical_classificationDrug Discovery | Hot PaperNatural productallergy protectionAllergy preventionCommunicationOrganic ChemistrycarbohydratesAirway inflammationTreatment optionsTotal synthesisGeneral Chemistryairway inflammationPolysaccharideCommunicationsCatalysisarabinogalactanchemistry.chemical_compoundchemistryBiochemistryArabinogalactanCarrier proteintotal synthesisChemistry – A European Journal
researchProduct

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms

2021

Neuroendocrine neoplasms (NENs) are heterogeneous neoplasms which arise from neuroendocrine cells that are distributed widely throughout the body. Although heterogenous, many of them share their ability to overexpress somatostatin receptors (SSTR) on their cell surface. Due to this, SSTR and somatostatin have been a large subject of interest in the discovery of potential biomarkers and treatment options for the disease. The aim of this review is to describe the molecular characteristics of somatostatin and somatostatin receptors and its application in diagnosis and therapy on patients with NENs as well as the use in the near future of somatostatin antagonists.

endocrine systemQH301-705.5CellMedicine (miscellaneous)ReviewGeneral Biochemistry Genetics and Molecular BiologymedicineBiology (General)Tumorspeptide receptor radionuclide therapyReceptors d'hormonesneuroendocrine neoplasmssomatostatin analoguesSomatostatin receptorbusiness.industryTreatment optionsLU-DOTA-TATEmedicine.anatomical_structureSomatostatinPotential biomarkerssomatostatin receptorssomatostatin antagonistsCancer research68Ga PETbusinesshormones hormone substitutes and hormone antagonistsBiomedicines
researchProduct

Use of Antihypertensive Drugs During Preeclampsia

2018

Treatment of pregnancy-related hypertensive disorders, such as preeclampsia (PE), remain a challenging problem in obstetrics. Typically, aggressive antihypertensive drug treatment options are avoided to prevent pharmacological-induced hypotension. Another major concern of administering antihypertensive drugs during pregnancy is possible adverse fetal outcome. In addition, management of hypertension during pregnancy in chronic hypertensive patients or in patients with prior kidney problems are carefully considered. Recent studies suggest that PE patients are at increased cardiovascular risk postpartum. Therefore, these patients need to be monitored postpartum for the subsequent development o…

lcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyhypertensionmedicine.drug_classMini ReviewCardiovascular MedicinePreeclampsiapreeclampsia03 medical and health sciences0302 clinical medicineMedicineIn patient030212 general & internal medicineAntihypertensive drugIntensive care medicinePregnancy030219 obstetrics & reproductive medicinebusiness.industrycardiovascularTreatment optionsmedicine.diseaseReview articlelcsh:RC666-701antihypertensive drugsFetal outcomepregnancyCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct

Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials

2015

Bipolar disorder (BD) is a recurrent, lifelong illness with high risks of disability and excess mortality. Despite many treatment options with demonstrated short-term efficacy, evidence concerning long-term treatment effectiveness in BD remains limited and the relative value of naturalistic studies versus randomized, controlled trials (RCTs) in its assessment, uncertain. Systematic computer-searching yielded 10 naturalistic studies and 15 RCTs suitable for analysis of recurrence rates and their association with treatments and selected clinical factors. In naturalistic studies (3904 BD subjects, 53.3% women, 85.8% BD-I, mean onset age 29.1, followed up to 2.1 years), the pooled recurrence ra…

medicine.medical_specialtyBipolar DisorderCIENCIAS MÉDICAS Y DE LA SALUDmedicine.medical_treatmentCiencias de la SaludPlaceboRELAPSElaw.inventionRandomized controlled trialRecurrencelawInternal medicinemedicineHumansPharmacology (medical)Bipolar disorderPsychiatryBiological PsychiatryDepression (differential diagnoses)Randomized Controlled Trials as TopicPharmacologyExcess mortalitySalud OcupacionalNATURALISTICTreatment optionsBIPOLAR DISORDERmedicine.diseaseDEPRESSIONPsychiatry and Mental healthTreatment OutcomeAnticonvulsantNeurologyNeurology (clinical)Psychology
researchProduct

Informing MS patients on treatment options: a consensus on the process of consent taking

2020

Abstract\ud In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process.\ud Aims\ud The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice.\ud Results\ud The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the…

medicine.medical_specialtyConsensusProcess (engineering)media_common.quotation_subjectDermatologyDisease modifying treatment; Informed consent; Multiple sclerosisMultiple sclerosis03 medical and health sciences0302 clinical medicineResource (project management)Informed consentDisease modifying treatmentmedicineHumans030212 general & internal medicineInformed consentEmpowermentmedia_commonPhysician-Patient Relationsbusiness.industryTreatment optionsGeneral MedicineClinical PracticePsychiatry and Mental healthItalyFamily medicineDisease modifying treatment; Informed consent; Multiple sclerosis; Consensus; Humans; Italy; Physician-Patient Relations; Informed Consent; Multiple SclerosisSettore MED/26 - NeurologiaNeurology (clinical)Decision processbusiness030217 neurology & neurosurgery
researchProduct

Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application

2005

To date, various strategies have been developed in order to prevent or to slow down the progression of Alzheimer's disease (AD). Despite the medical need for an effective therapeutic treatment of AD, progress towards this goal is painstakingly slow. Although AD is the most common neurodegenerative disorder and a large amount of primary basic and clinical research has been performed already, it appears very difficult to identify appropriate targets, which would promise fast, effective and safe strategies to combat the disease onset and progression. In this review, we present some of clinically applied treatment options, which may improve AD symptoms for a short period but so far lack the abi…

medicine.medical_specialtyDisease onsetMechanism (biology)business.industryTherapeutic treatmentTreatment optionsCell BiologyDiseasemedicine.diseasePathology and Forensic MedicineSurgeryDegenerative diseaseClinical researchmedicineAlzheimer's diseaseIntensive care medicinebusinessMolecular BiologyInternational Journal of Experimental Pathology
researchProduct